Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Kelly Maloney

Concepts (352)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
36
2023
267
5.690
Why?
Down Syndrome
6
2023
328
1.660
Why?
Antineoplastic Combined Chemotherapy Protocols
16
2022
1385
1.550
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
9
2023
65
1.480
Why?
Asparaginase
8
2020
28
0.980
Why?
Burkitt Lymphoma
2
2020
53
0.860
Why?
Child
65
2023
19033
0.790
Why?
Consolidation Chemotherapy
2
2019
8
0.770
Why?
Leukemia, Myeloid, Acute
5
2022
532
0.740
Why?
Child, Preschool
45
2023
9448
0.670
Why?
Leukemia
4
2021
208
0.630
Why?
Mercaptopurine
5
2017
15
0.590
Why?
Disease-Free Survival
11
2023
649
0.590
Why?
Oncogene Proteins, Fusion
5
2021
179
0.570
Why?
Neoplasm Recurrence, Local
4
2023
895
0.560
Why?
Antineoplastic Agents
7
2019
1967
0.540
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
2016
92
0.530
Why?
Preleukemia
1
2015
2
0.520
Why?
Molecular Targeted Therapy
3
2021
355
0.510
Why?
Drug Hypersensitivity
3
2017
85
0.500
Why?
Leukemia, Monocytic, Acute
1
2014
4
0.490
Why?
Sarcoma, Myeloid
1
2014
4
0.490
Why?
Neoplasm, Residual
7
2023
103
0.480
Why?
Prognosis
13
2021
3424
0.480
Why?
Infant
32
2023
8254
0.470
Why?
Bone Marrow Transplantation
1
2014
244
0.440
Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
2023
16
0.430
Why?
Adolescent
37
2023
18364
0.430
Why?
Acute Kidney Injury
1
2019
705
0.420
Why?
Erwinia
2
2020
3
0.420
Why?
Tumor Suppressor Proteins
3
1999
287
0.410
Why?
Chromosome Aberrations
2
2022
136
0.410
Why?
Recurrence
9
2023
971
0.400
Why?
Hematopoietic Stem Cell Transplantation
2
2019
539
0.400
Why?
Neutropenia
2
2022
131
0.390
Why?
Humans
77
2023
118251
0.390
Why?
Male
53
2023
57474
0.390
Why?
Stem Cell Transplantation
3
2019
151
0.380
Why?
Rhabdomyosarcoma
1
2011
56
0.370
Why?
Lymphoma, Large B-Cell, Diffuse
2
2022
94
0.370
Why?
Cell Cycle Proteins
3
1999
563
0.370
Why?
Sarcoma, Ewing
1
2011
65
0.370
Why?
Carrier Proteins
3
1999
725
0.360
Why?
Ploidies
2
2019
18
0.350
Why?
Catheter-Related Infections
2
2022
60
0.340
Why?
Core Binding Factor Alpha 2 Subunit
3
2021
30
0.330
Why?
Genes, Tumor Suppressor
2
1999
77
0.330
Why?
Cyclophosphamide
4
2019
222
0.330
Why?
Catheterization, Central Venous
2
2022
95
0.320
Why?
Female
50
2023
61261
0.320
Why?
Philadelphia Chromosome
2
2018
15
0.310
Why?
Survival Rate
7
2021
1716
0.290
Why?
Medication Adherence
3
2017
554
0.280
Why?
Vincristine
4
2021
99
0.280
Why?
Gene Deletion
2
1998
359
0.280
Why?
Trisomy
2
2021
65
0.280
Why?
Etoposide
2
2019
149
0.270
Why?
Antimetabolites, Antineoplastic
2
2017
83
0.270
Why?
Neoplasm Proteins
2
2018
398
0.270
Why?
Treatment Outcome
12
2023
9319
0.250
Why?
Young Adult
14
2023
10731
0.250
Why?
Anxiety
3
2016
845
0.250
Why?
Cyclin-Dependent Kinase Inhibitor p16
3
1999
58
0.240
Why?
Medical Oncology
4
2022
229
0.220
Why?
Gene Rearrangement
3
2019
141
0.220
Why?
Polyethylene Glycols
5
2020
575
0.210
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2023
59
0.210
Why?
Leukemia, Myelomonocytic, Juvenile
1
2022
2
0.210
Why?
Induction Chemotherapy
2
2019
59
0.210
Why?
Adult
22
2023
31324
0.210
Why?
Central Venous Catheters
1
2022
42
0.210
Why?
Doxorubicin
2
2022
301
0.210
Why?
Lymphoma
1
2023
179
0.200
Why?
Prednisone
2
2019
235
0.200
Why?
Program Evaluation
2
2017
838
0.200
Why?
Lung Neoplasms
1
2014
2216
0.200
Why?
Translocation, Genetic
2
2013
89
0.190
Why?
Polymorphism, Single Nucleotide
3
2017
2057
0.180
Why?
Risk Factors
11
2022
8958
0.180
Why?
Maintenance Chemotherapy
2
2017
23
0.180
Why?
Bacterial Infections
1
2022
226
0.180
Why?
Diploidy
1
2019
11
0.180
Why?
Immunocompromised Host
1
2021
198
0.180
Why?
Genes, p16
1
1999
18
0.170
Why?
Prospective Studies
9
2022
6443
0.170
Why?
PAX5 Transcription Factor
1
2019
12
0.170
Why?
Hyperglycemia
1
2023
313
0.170
Why?
Antibodies, Bispecific
1
2019
33
0.170
Why?
Myelodysplastic Syndromes
1
2020
118
0.170
Why?
Chromosomes, Human, Pair 19
1
1998
25
0.170
Why?
Chromosomes, Human, Pair 17
1
1998
62
0.170
Why?
Rituximab
1
2019
153
0.160
Why?
Mutagenesis
1
1999
176
0.160
Why?
Chromosomes, Human, Pair 1
1
1998
72
0.160
Why?
Patient Safety
1
2021
281
0.160
Why?
Quality of Life
2
2021
2355
0.160
Why?
Prostate-Specific Antigen
2
2009
155
0.160
Why?
Substance Withdrawal Syndrome
1
2020
157
0.150
Why?
Proto-Oncogenes
1
1997
27
0.150
Why?
Family Relations
2
2016
84
0.150
Why?
Oncologists
1
2017
31
0.150
Why?
Thionucleotides
1
2017
34
0.150
Why?
Apyrase
1
2017
13
0.150
Why?
Thioguanine
1
2017
20
0.150
Why?
Follow-Up Studies
6
2021
4574
0.150
Why?
Blast Crisis
1
2016
19
0.140
Why?
Depression
2
2016
1133
0.140
Why?
Carboxypeptidases A
1
2016
2
0.140
Why?
Retrospective Studies
9
2023
12929
0.140
Why?
Genomics
2
2022
668
0.140
Why?
Pediatricians
1
2017
120
0.140
Why?
Sepsis
1
2022
531
0.140
Why?
Mentors
2
2017
165
0.140
Why?
Mentoring
1
2017
101
0.140
Why?
Osteonecrosis
1
2015
19
0.140
Why?
Gene Expression Regulation, Enzymologic
1
2017
287
0.130
Why?
Nausea
1
2016
107
0.130
Why?
Longitudinal Studies
7
2016
2491
0.130
Why?
Central Nervous System Neoplasms
1
2017
128
0.130
Why?
Adrenal Cortex Hormones
1
2019
517
0.130
Why?
Pancreatitis
1
2016
105
0.130
Why?
Mutation
4
2022
3435
0.130
Why?
Dexamethasone
4
2021
319
0.130
Why?
Fusion Proteins, bcr-abl
2
2016
60
0.130
Why?
High-Throughput Nucleotide Sequencing
1
2017
449
0.130
Why?
Monitoring, Physiologic
1
2017
268
0.130
Why?
Bacteremia
1
2016
161
0.120
Why?
Cyclin-Dependent Kinase Inhibitor p15
3
1999
14
0.120
Why?
Myeloid-Lymphoid Leukemia Protein
2
2010
64
0.120
Why?
Antigens, CD
1
2017
457
0.120
Why?
Flow Cytometry
1
2018
1072
0.120
Why?
Cross Infection
1
2016
204
0.120
Why?
Repressor Proteins
1
1997
378
0.120
Why?
Histone-Lysine N-Methyltransferase
2
2010
99
0.120
Why?
Immunotherapy
1
2018
493
0.120
Why?
Pediatrics
3
2021
980
0.120
Why?
DNA-Binding Proteins
2
1998
1343
0.120
Why?
Chromosomes, Human, Pair 21
1
2013
33
0.120
Why?
Life Change Events
1
2014
132
0.120
Why?
Venous Thromboembolism
1
2017
233
0.120
Why?
Quality Improvement
1
2021
962
0.120
Why?
Self Report
1
2017
698
0.110
Why?
Transcription Factors
2
1998
1567
0.110
Why?
Leukemia, Megakaryoblastic, Acute
1
2012
11
0.110
Why?
Karyotyping
3
2019
102
0.110
Why?
Myeloproliferative Disorders
1
2012
25
0.110
Why?
Contraindications
1
2012
86
0.100
Why?
Arabinonucleosides
1
2011
8
0.100
Why?
Adenine Nucleotides
1
2011
20
0.100
Why?
Antibodies, Monoclonal
1
2018
1279
0.100
Why?
Cohort Studies
5
2021
5078
0.100
Why?
Prostatic Neoplasms
2
2009
939
0.100
Why?
Chromosomes, Human, Pair 4
1
2010
28
0.090
Why?
Chromosomes, Human, Pair 10
1
2010
19
0.090
Why?
T-Lymphocytes
1
2018
1770
0.090
Why?
Pain
1
2016
736
0.090
Why?
Parents
2
2016
1208
0.090
Why?
Multivariate Analysis
4
2015
1469
0.090
Why?
Age Factors
8
2019
2990
0.090
Why?
Prostatectomy
1
2009
99
0.080
Why?
Neoplasm Metastasis
1
2011
541
0.080
Why?
Bloom Syndrome
1
1988
1
0.080
Why?
Juxtaglomerular Apparatus
1
2007
1
0.080
Why?
Gene Expression Regulation, Leukemic
2
2016
49
0.080
Why?
Polymerase Chain Reaction
1
2010
1004
0.070
Why?
Blood Coagulation
1
2008
202
0.070
Why?
Stress, Psychological
1
2014
967
0.070
Why?
Drug Administration Schedule
2
2017
734
0.070
Why?
Methotrexate
2
2017
227
0.070
Why?
Remission Induction
2
2019
246
0.060
Why?
Drug Monitoring
2
2017
185
0.060
Why?
Acute Disease
2
2019
933
0.060
Why?
Personal Satisfaction
2
2017
183
0.060
Why?
Administration, Oral
2
2017
753
0.060
Why?
Kidney Neoplasms
1
2007
333
0.060
Why?
Genetic Variation
1
1988
912
0.060
Why?
Disease Progression
2
2021
2477
0.050
Why?
Randomized Controlled Trials as Topic
2
2020
1237
0.050
Why?
Risk
5
2023
849
0.050
Why?
Transcriptome
2
2019
752
0.050
Why?
Proto-Oncogene Proteins c-cbl
1
2022
12
0.050
Why?
Incidence
2
2019
2413
0.050
Why?
Exome
1
2022
210
0.050
Why?
Drug Therapy
1
2021
76
0.050
Why?
Diarrhea
2
1999
180
0.050
Why?
Risk Assessment
3
2017
3043
0.050
Why?
Bone Marrow
1
2022
252
0.050
Why?
Surveys and Questionnaires
3
2017
4684
0.050
Why?
Endocrine Glands
1
1979
16
0.050
Why?
Blood Cell Count
1
1999
52
0.040
Why?
Viral Load
1
2021
406
0.040
Why?
Chromosomes, Human
1
2019
40
0.040
Why?
Azacitidine
1
2020
119
0.040
Why?
Cytogenetic Analysis
1
2019
28
0.040
Why?
Loss of Heterozygosity
1
1999
40
0.040
Why?
Mosaicism
1
2019
62
0.040
Why?
Bridged Bicyclo Compounds, Heterocyclic
1
2020
164
0.040
Why?
Interviews as Topic
1
2021
593
0.040
Why?
Genome-Wide Association Study
2
2016
1318
0.040
Why?
Infant, Newborn
4
2019
5230
0.040
Why?
Overweight
1
2023
492
0.040
Why?
United States
4
2021
12488
0.040
Why?
Disinfectants
1
1999
33
0.040
Why?
Sequence Deletion
1
1999
169
0.040
Why?
Chromosomes
1
2019
87
0.040
Why?
National Cancer Institute (U.S.)
1
2018
43
0.040
Why?
Hypertension
1
2007
1199
0.040
Why?
Escherichia coli O157
1
1998
31
0.040
Why?
Feasibility Studies
1
2021
746
0.040
Why?
Methylation
1
1998
204
0.040
Why?
Community Participation
1
1999
120
0.040
Why?
Family
1
2021
578
0.040
Why?
Public Health Surveillance
1
2017
57
0.040
Why?
Erythrocyte Count
1
2017
19
0.040
Why?
Glucose
1
2023
940
0.040
Why?
Genetic Predisposition to Disease
2
2017
2262
0.040
Why?
Food-Drug Interactions
1
2017
6
0.040
Why?
Leucovorin
1
2017
42
0.040
Why?
Escherichia coli Infections
1
1998
105
0.040
Why?
Biopsy
1
2021
1078
0.040
Why?
Injections, Intramuscular
1
2017
116
0.040
Why?
Proto-Oncogene Proteins c-ets
1
1997
51
0.040
Why?
Career Mobility
1
2017
65
0.040
Why?
Dairy Products
1
2017
31
0.040
Why?
Water Purification
1
1999
131
0.040
Why?
Sulfonamides
1
2020
444
0.040
Why?
Cranial Irradiation
1
2017
69
0.040
Why?
Cerebrospinal Fluid
1
2017
93
0.040
Why?
Middle Aged
10
2019
27510
0.040
Why?
MEF2 Transcription Factors
1
2016
57
0.040
Why?
Infusions, Intravenous
1
2017
379
0.040
Why?
Qualitative Research
1
2021
952
0.040
Why?
Leukocyte Count
1
2017
303
0.040
Why?
Methyltransferases
1
2017
61
0.040
Why?
NIH 3T3 Cells
1
2016
138
0.040
Why?
Luciferases
1
2016
142
0.040
Why?
Methyl Ethers
1
1996
8
0.040
Why?
Breast Neoplasms
5
1979
1957
0.030
Why?
Anesthetics, Inhalation
1
1996
13
0.030
Why?
Ethers
1
1996
17
0.030
Why?
Bone Morphogenetic Protein 7
1
2015
10
0.030
Why?
Fluorides
1
1996
47
0.030
Why?
Health Education
1
1999
317
0.030
Why?
Cytarabine
1
2016
53
0.030
Why?
Alternative Splicing
1
2017
190
0.030
Why?
Severity of Illness Index
2
2017
2659
0.030
Why?
Genotype
3
2017
1870
0.030
Why?
Intensive Care Units, Pediatric
1
2016
157
0.030
Why?
Histone Deacetylase Inhibitors
1
2016
200
0.030
Why?
Disease Management
1
2019
566
0.030
Why?
Homeodomain Proteins
1
1998
469
0.030
Why?
DNA Methylation
1
1999
501
0.030
Why?
Aged
9
2019
19594
0.030
Why?
HEK293 Cells
1
2017
625
0.030
Why?
Biomarkers, Tumor
1
2021
1056
0.030
Why?
Promoter Regions, Genetic
1
1999
1157
0.030
Why?
Sequence Analysis, RNA
1
2016
410
0.030
Why?
Algorithms
1
2021
1522
0.030
Why?
Blood Glucose
1
2023
1936
0.030
Why?
Income
1
2014
173
0.030
Why?
Marriage
1
2014
108
0.030
Why?
Behavior
1
2014
94
0.030
Why?
Psychomotor Agitation
1
2014
71
0.030
Why?
Demography
1
2014
273
0.030
Why?
Base Sequence
1
2016
2148
0.030
Why?
Case-Control Studies
2
2016
3156
0.030
Why?
Clinical Trials as Topic
1
2017
964
0.030
Why?
In Situ Hybridization, Fluorescence
1
2013
310
0.030
Why?
Odds Ratio
1
2015
993
0.030
Why?
Aggression
1
2014
184
0.030
Why?
Nucleoside Transport Proteins
1
2011
4
0.030
Why?
Erythrocytes
1
2017
619
0.030
Why?
Time Factors
2
2015
6368
0.030
Why?
Antineoplastic Agents, Alkylating
1
2011
69
0.030
Why?
Regression Analysis
1
2014
984
0.030
Why?
Escherichia coli
1
2015
757
0.020
Why?
Mice
2
2019
15446
0.020
Why?
Antineoplastic Agents, Phytogenic
1
2011
180
0.020
Why?
Bacteria
1
2016
751
0.020
Why?
Logistic Models
1
2015
1896
0.020
Why?
Survival Analysis
1
2013
1262
0.020
Why?
Obesity
1
2023
2715
0.020
Why?
Prevalence
1
2016
2321
0.020
Why?
Mice, Inbred C57BL
1
2019
4887
0.020
Why?
Kaplan-Meier Estimate
1
2011
840
0.020
Why?
Emotions
1
2014
494
0.020
Why?
Sister Chromatid Exchange
1
1988
4
0.020
Why?
Genetic Complementation Test
1
1988
62
0.020
Why?
Cell Fusion
1
1988
51
0.020
Why?
Plasminogen Activator Inhibitor 1
1
2008
74
0.020
Why?
Protein C
1
2008
42
0.020
Why?
Antithrombins
1
2008
51
0.020
Why?
Water Microbiology
2
1999
78
0.020
Why?
Fibrinogen
1
2008
150
0.020
Why?
Biomarkers
1
2017
3567
0.020
Why?
Genetic Markers
1
1988
347
0.020
Why?
Renin-Angiotensin System
1
2007
82
0.020
Why?
Biopsy, Needle
1
2007
188
0.020
Why?
Transplantation, Homologous
1
2008
412
0.020
Why?
Rare Diseases
1
2007
93
0.020
Why?
Blood Pressure Determination
1
2007
133
0.020
Why?
Nephrectomy
1
2007
162
0.020
Why?
Animals
2
2019
33152
0.020
Why?
RNA, Messenger
1
2011
2657
0.010
Why?
Immunohistochemistry
1
2007
1681
0.010
Why?
Cell Line
1
1988
2693
0.010
Why?
Estriol
1
1979
6
0.010
Why?
Menstruation
1
1979
36
0.010
Why?
Estrone
1
1979
36
0.010
Why?
Prolactin
1
1979
96
0.010
Why?
Bolivia
1
1999
60
0.010
Why?
Luteinizing Hormone
1
1979
173
0.010
Why?
Follicle Stimulating Hormone
1
1979
216
0.010
Why?
Restaurants
1
1998
17
0.010
Why?
Food Handling
1
1998
48
0.010
Why?
Swimming
1
1998
46
0.010
Why?
Progesterone
1
1979
242
0.010
Why?
Disease Transmission, Infectious
1
1998
56
0.010
Why?
Water Supply
1
1998
71
0.010
Why?
Meat
1
1998
89
0.010
Why?
Estradiol
1
1979
473
0.010
Why?
Halothane
1
1996
5
0.010
Why?
Population Surveillance
1
1999
413
0.010
Why?
Analysis of Variance
1
1999
1288
0.010
Why?
Feces
1
1998
392
0.010
Why?
Ovarian Neoplasms
1
1978
420
0.010
Why?
Pedigree
3
1978
485
0.010
Why?
Kidney
1
1996
1351
0.010
Why?
Aged, 80 and over
1
1999
6541
0.000
Why?
Nebraska
2
1976
9
0.000
Why?
New York
2
1976
113
0.000
Why?
Genes
1
1978
227
0.000
Why?
Genetic Linkage
1
1978
321
0.000
Why?
Oncogenic Viruses
1
1976
3
0.000
Why?
Apocrine Glands
1
1976
4
0.000
Why?
Genetic Techniques
1
1976
60
0.000
Why?
Pheochromocytoma
1
1976
54
0.000
Why?
Klinefelter Syndrome
1
1976
53
0.000
Why?
Syndrome
1
1976
343
0.000
Why?
Pregnancy
2
1978
5671
0.000
Why?
Statistics as Topic
1
1976
307
0.000
Why?
HLA Antigens
1
1976
223
0.000
Why?
Skin Diseases
1
1976
125
0.000
Why?
Sarcoma
1
1976
137
0.000
Why?
Abnormalities, Multiple
1
1976
182
0.000
Why?
Sex Factors
1
1978
1765
0.000
Why?
Thyroid Neoplasms
1
1976
278
0.000
Why?
Neoplasms
2
1976
2160
0.000
Why?
Melanoma
1
1976
664
0.000
Why?
Registries
1
1976
1806
0.000
Why?
Phenotype
1
1976
2937
0.000
Why?
Brain Neoplasms
1
1976
1019
0.000
Why?
Maloney's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)